Page 113 - Early Development News Today

Registration is disabled. ); }, success: function(response) { $(.megamenuthird[data-menu= + $data_megamenu + -articles]).html(response); }, error: function(xhr) { // if error occured $(.megamenuthird[data-menu= + $data_megamenu + -articles]).html("Error occured.please try again"); } }); } } //Child Level Menu Hover function get_childlevelmenu(currentid){ //console.log(current id +currentid); var $currentelement = $(#+currentid); $(.menu-item-+$(#+curr...

Investegate announcements from Frontier IP Group, Exscientia collaboration with Bristol Myers Squibb

Exscientia. The agreement includes up to $50 million in upfront funding, up to $125 million in near to mid-term potential milestones, and additional clinical, regulatory and commercial payments that take the potential value of the deal beyond $1.2 billion. Exscientia will also receive royalties on net sales of any marketed drug products resulting from the collaboration. The biotech industry is increasingly using AI to deploy targeted drug molecules to test the efficacy of drugs to tackle illnes...

MIAMI – Today in aviation, the Sukhoi Superjet 100, the first all-new commercial aircraft in post-Soviet Russia, flew for the first time in 2008. The type flew for the first time commercially on April 21, 2011, with Armavia (U8). Sukhoi Civil Aircraft, a subsidiary of the United Aircraft Corporation (now Regional Aircraft – a branch of the Irkut Corporation), produced the Sukhoi Superjet 100 or SSJ100. Production of the type began in 2000. On January 28, 2007, the first SSJ was transporte...

Thu, 05/13/2021 LAWRENCE — By many estimates, the Montessori educational approach is the most prevalent alternative pedagogy model in public schools across the United States. While its history stretches back a century, the Montessori model has historically been underrepresented in the field of educational research. One researcher leading the charge into examining the Montessori education model is Angela Murray, director of the Center for Montessori Research (CMR) within the Achievement and As...

Interline Therapeutics Raises $92M in Funding The round was led by Foresite Capital and ARCH Venture Partners. The company intends to use the funds to expand the research platform and advance six preclinical therapeutic programs. Co-founded by CEO Zachary Sweeney, Interline Therapeutics is a Foresite Labs incubated company that focuses on systematically elucidating protein communities to define molecular mechanisms of disease. The company uses genomics, proteomics, structural biology and compu...

Governor Dunleavy Creates Task Force on Broadband   Tuesday PM (SitNews) Anchorage, Alaska - Alaska Governor Mike Dunleavy last week signed Administrative Order No. 322  to establish the Governor’s Task Force on Broadband (Task Force) to address the growing need for reliable, high speed connectivity for all Alaskans. “On the heels of a global pandemic, now more than ever do we see the critical role that the internet plays in nearly every part of life and the importance ...

Sierra Oncology Reports First Quarter 2021 Results News provided by Share this article – Topline Data Now Expected in Q1 2022 – SAN MATEO, Calif., May 7, 2021 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer, today reported its financial and operating results for the first quarter ended March 31, 2021. "The first quarter of 2021 has been a hugely productive one for Sierra. We are ex...

Northwood Elementary teacher named Alaska Teacher of the Year Megan Pacer © Anchorage School District Commissioner Michael Johnson presents Kelly Shrein with a plaque commemorating her designation of 2021-2022 Alaska Teacher of the Year. ANCHORAGE, Alaska (KTUU) - A local Anchorage elementary school teacher has been named the 2021-22 Alaska Teacher of the Year. Kelly Shrein, who teaches at Northwood Elementary School, was chosen this year for the honor, the Alaska Department ...

Search jobs 06-May-2021 Evotec launches beLAB1407 to accelerate translational research from the UKs academic life science ecosystem in collaboration with Bristol Myers Squibb DGAP-News: Evotec SE / Key word(s): Miscellaneous 06.05.2021 / 07:30 beLAB1407 TRANSLATES ACADEMIC INNOVATION FROM LEADING ACADEMIC INSTITUTIONS IN THE UK THE COLLABORATION LEVERAGES EVOTECS UNIQUE MULTIMODALITY PLATFORM TO VALIDATE FIRST-IN-CLASS THERAPEUTIC CONCEPTS FROM THE...